Acellular Human Nerve Allografts as a Means to Decrease Sensory Deficits following Peripheral Nerve Biopsy

Overview

About this study

The ourpose of this study is to Investigate the effectiveness of acellular human nerve allografts in decreasing sensory deficits following peripheral nerve biopsy.   

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individual is scheduled to have a peripheral nerve biopsy.
  • Individual will undergo peripheral nerve harvest for facial re-animation surgery
  • Age above 18 years old.

Exclusion Criteria: 

  • Patient refuses to give informed consent for study
  • Any evidence of neurological deficit affecting the area supplied by biopsied nerve

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Samir Mardini, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions